Results

Total Results: 1,541 records

Showing results for "months".

381. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - depending on expert comments received on interventions issued for comment during the preceding 6 months … followed by a buprenorphine implant placed under the skin in a physician’s office and removed after 6 months

382. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
     April 01, 2022 - ), intermediate-term followup (6 to <12 months), and long-term followup (≥12 months)? … ), intermediate-term followup (6 to <12 months), and long-term followup (≥12 months)? … ), intermediate-term followup (6 to <12 months), and long-term followup (≥12 months)? … Populations and Conditions All KQs: Adults (age ≥18 years) with chronic pain (pain lasting >3 months … ), intermediate- (6 to <12 months), and long-term (≥12 months) treatment duration • Studies or outcomes

383. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
     December 06, 2010 - Other adverse effects • Timing: Minimum of three months duration of follow-up • Settings: … and cross-sectional studies • Meta-analyses or systematic reviews Study duration must be three months … the peer review comments are documented and will, for CERs and Technical briefs, be published three months

384. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_research-protocol.pdf
     December 06, 2010 - Other adverse effects • Timing: Minimum of 3 months of follow-up • Settings: Primary care … studies, and cross-sectional studies • Meta-analyses or systematic reviews Study duration must be 3 months … of the peer review comments are documented and will, for CERs and Technical Briefs, be published e months

385. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
     January 01, 2024 - In patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks to <6 months) … : Benefits of cannabinoids for chronic pain compared with placebo in the short term (4 weeks to <6 months … Question 2: Harms of cannabinoids for chronic pain compared with placebo in the short term (4 weeks to <6 months

386. Disposition of Comments: CER 230 Therapies for Clinically Localized Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-230-prostate-cancer-comments.pdf
     September 17, 2020 - the authors’ responses to the comments are posted for public viewing on the Web site approximately 3 months

387. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_june_2012.pdf
     January 01, 2012 - depending on expert comments received on interventions issued for comment during the preceding 6 months … This report was based on results in 158 patients whose children were evaluated at 12 months. … (by 30 months). … This report is based on results in 158 patients whose children were evaluated at 12 months. … and ambulation by 30 months.

388. Disposition of Comments for Evidence Report 221 Behavioral Programs for Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_disposition-comments.pdf
     September 28, 2015 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … TEP 1 General The analyses included the change (primarily) in A1c and body weight at 12/24 months. … There is no mention that most of the programs delivered were less than 6 months in duration and often … TEP 3 General A1c results at 12 months are not typically significant if there isn’t ongoing support … Only eight trials had followup longer than 6 months.

389. Disposition of Comments for Migraine in Adults: Preventive Pharmacologic Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
     April 18, 2013 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … Pediatric safety trials should examine adverse effects at 12 months or more. … small nonrandomized study demonstrated that 8 percent of adolescents treated with botox 100U every 3 months

390. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - CKD has been defined as decreased kidney function and/ or kidney damage persistent for at least 3 months … diagnosis of CKD requires that impairment in kidney function or kidney damage persist for at least 3 months … that required repeated or sustained kidney abnormalities for entry did not mandate persistence for 3 months … treatment, and been less likely to develop progressive CKD than patients with CKD confirmed over 3 months … of individuals with abnormal one-time abnormalities who meet the criteria for CKD for at least 3 months

391. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
     December 01, 2013 - depending on expert comments received on interventions issued for comment during the preceding six months … and 12 months compared with usual care … but not 12 months. … Patient followup of a mean of 5 months was reported. … One patient relapsed at 7 months after therapy.

392. Management of Infantile Hemangioma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_policymaker.pdf
     June 01, 2016 - Most IH lesions undergo rapid initial proliferation, plateau in infants aged about 9 to 12 months, and

393. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
     November 01, 2009 - The reported followup periods ranged from 5 to 157 months (median, 36 months) for 188 studies that commented … For example, in patients with glial tumors it ranged from 5 to 39 months, whereas in patients with … uveal melanoma it ranged from 6 to 120 months. … A typical definition for late events was at least 3 months after the radiation treatment. … Studies report results over long followup periods (in excess of 12 months); however it is not clear

394. CER 210: Disposition of Comments for Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
     January 01, 2020 - the authors’ responses to the comments are posted for public viewing on the Web site approximately 3 months … By the time of public comment and then publication, the literature search will be more than 12 months … Among women who were age 50 to 59 years at baseline, those with a lifetime lactation of 7-12 months … One of the biggest issues is defining exclusive breastfeeding at six months since some new research … encourages the introduction of solids before six months if developmentally indicated (Robert Wood

395. Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_executive.pdf
     January 01, 2020 - children and adolescents, 2011 Vaccine Age DTaP (diphtheria, tetanus, and acellular pertussis) 2 months … –6 years Hepatitis A 12 months and older Hepatitis B Birth and older Hib (Haemophilus influenzae type … b) 6 weeks–59 months HPV (human papillomavirus) 9 years–21 years (male) 9 years–26 years (female) … Tdap (tetanus, diphtheria, and acellular pertussis) 7 years and older Varicella 12 months and older … of age, compared to a high of five per 100,000 person-days at 17 months of age.

396. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
     January 01, 2020 - The investigators found that the interventions decreased weight by 2.8 pounds, on average, at 6–12 months … outcomes, adverse effects and quality of life, additional time points of interest include 3 and 6 months … the intermediate outcomes, safety and quality of life outcomes the timepoints of interest are: 3 months … , 6 months, 1 year, 3 years, 5 years and later than 5 years if available … the peer review comments are documented and will, for CERs and Technical briefs, be published three months

397. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - depending on expert comments received on interventions issued for comment during the preceding 6 months … Scanning System despite extensive scanning since inception, and more recently (in the past 15–18 months

398. Noninvasive Treatments for Low Back Pain: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
     November 01, 2016 - pain at some time in their lives, and over one quarter of U.S. adults report recent (in the last 3 months … scale) to moderate (10 to 20 points) range. �� Outcomes were mostly measured at short-term (up to 6 months

399. Treating Infantile Hemangiomas in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_consumer.pdf
     June 01, 2016 - The IH may grow very quickly in the first few months of life and may continue to grow until around … Treatment with medicines taken by mouth or gel drops put on the IH usually lasts about 9 to 15 months

400. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
     January 01, 2011 - Annual Incidence of Foot Ulcer Among Diabetic Medicare Parts A and B Fee-for-Service (FFS) Beneficiaries, 2006-2008, by Age, Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) Algorithm 3: 12-month period of continuous enrollment and continuous FFS enrollment throughout the year. Age…